D-Eye Srl names Galileo Diagnostics, commercial branch of Genclis SA, international distributor for Veterinary Market
March 18, 2015 17:51 ET
|
Genclis SAS
NANCY, France and PADOVA, Italy and PASADENA, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- D-Eye, a leading developer of advanced devices for mass health screenings and data analytics, and Genclis, a...
Genclis selected to present its diagnostic technology Severidia(R) at the St. Gallen International Breast Cancer Conference
January 09, 2015 01:35 ET
|
Genclis SAS
NANCY, France, Jan. 9, 2015 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, today announced that its communication on "using next generation sequencing...
Genclis SAS : Confirms Potential of its Severidia(R) Test on 47 TNBC patients
November 25, 2014 01:37 ET
|
Genclis SAS
100% of patients classified with Severidia® in the "good outcome" subgroup were alive after 2,500 days
Improved p value (p < 10-5)
NANCY, France, Nov. 25, 2014 (GLOBE NEWSWIRE)...
Genclis SAS Coordinate a Roundtable in a Molecular Allergology Seminar
November 20, 2014 15:24 ET
|
Genclis SAS
NANCY, France, Nov. 20, 2014 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, will attend the 2nd French Molecular Allergology Seminar in Paris on...
Genclis SAS Releases First Data for Severidia(r) Molecular Diagnostic in Triple-Negative Breast Cancer
October 29, 2014 12:04 ET
|
Genclis SAS
NANCY, France, Oct. 29, 2014 (GLOBE NEWSWIRE) -- Genclis, a molecular diagnostic company in the fields of allergy and cancer, announced today the presentation of the first clinical data for its...
Genclis SAS appoints Mr. Stephane Boissel as CEO
October 13, 2014 10:43 ET
|
Genclis SAS
NANCY, France, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Genclis, an innovative diagnostic company in the fields of allergy and cancer, announced today the appointment of Mr. Stéphane Boissel as CEO. His...